Papers to Appear in Forthcoming Issues

(Received and Accepted Dates Follow Title) isrupted for the KvLQT1 Potassium Channel Regulator IsK Gene Accumulate Mature T Cells. Dominique Chabannes, Jacques Barhanin, and Denis Escande. (Received 9/27/00; accepted 3/7/01.) ve and Negative Consequences of Soluble Fas Ligand Produced by an Antigen-Specific CD4+ T Cell Response in Human Carcinoma Immune Interactions. Elke S. Bergmann-Leitner and Scott I. Abrams. (Received 12/18/00; accepted 3/7/01.) lar Cloning and Expression Pattern of Porcine Myeloid DAP12-Associating Lectin-1. Daesong Yim, Hyun-Bae Jie, John Sotiriadis, Yoon-Sang Kim, and Yoon B. Kim. (Received 12/13/00; accepted 3/4/01.) igation Enhances Cell Cycle Turnover of Ag-Activated CD4 T Cells in Vivo. Amy R. Weatherill, Joseph R. Maxwell, Chikara Takahashi, Andrew D. Weinberg, and Anthony T. Vella. (Received 1/23/01; accepted 3/10/01.) very of DNA Coding for the Soluble Form of CD86 Results in the Down-Regulation of the Immune Response to DNA Vaccines. Juan Fló, Sergio Tisminetzky, and Francisco Baralle. (Received 10/23/00; accepted 3/18/01.) tic Cells Issued in Vitro from Bone Marrow Produce PGE2 That Contributes to the Immunomodulation Induced by Antigen-Presenting Cells. H. Harizi, M. Juzan, C. Grosset, M. Rashedi, and N. Gualde. (Received 11/24/00; accepted 3/15/01.) meric” C57L-Derived Ly49 Inhibitory Receptor Resembling the Ly49D Activation Receptor. Indira K. Mehta, Hamish R. C. Smith, Jian Wang, David H. Margulies, and Wayne M. Yokoyama. (Received 1/17/01; accepted 3/14/01.) pic–Anti-idiotypic B Cell Interactions Generated against a Protective Antigen of a Morbillivirus in Mice. Shibani Mitra-Kaushik, M. S. Shaila, Anjali Karanade, and Rabindranath Nayak. (Received 10/16/00; accepted 3/22/01.)